e10 Abstracts / Research in Social and Administrative Pharmacy 8 (2012) e1–e66

4. Share the experiences of participants into their

practice

5. Conclude the general pharmacist’s roles both in

conventional and emerging activities

SOCIAL PHARMACY WORKSHOP 4: NEW ANDEMERGING ROLES AND RESEARCH

Perceived Barriers to Social Pharmacy ResearchW. Winit-Watjana1, 1Department of Pharmacy, Health

and Well-being, Faculty of Applied Sciences, University of

Sunderland, UK

Introduction: Social pharmacy (SP), which is widely

known as “social and administrative pharmacy” (SAP),

has been established in Scandinavian countries and the

US over the past 40 years. The concepts of SP have also

been widely adopted by pharmacy researchers in many

countries. In the UK and some commonwealth coun-

tries, SP may however be subsumed within the term

“pharmacy practice”. According to research journals

and meetings, SP issues in recent years include health-

care reforms, patients and drug safety, pharmacoeco-

nomics and quality of life, public health and information

technology in pharmacy. Although numerous SP crucial

issues have been addressed, there are still some barriers,

together with facilitators, to SP research in terms of

research design, data analysis, funding, costing, ethical

approval and lack of research teams. It is of paramount

importance for researchers to be aware of these barriers

and solutions to the problems so that they can create

more quality SP research and develop collaborative

research in the future.

Aims of the Workshop: This workshop is aimed to

present Top 10 current issues in SP and perceived

barriers to SP research, and to investigate actual barriers

perceived by international audience.

Learning Objectives: Participants should be able to

explain Top 10 current issues in SP and elaborate the

perceived barriers to SP research.

Description of Workshop Activities: The workshop will

last approximately two hours. It will start with a 40-

minute PowerPoint presentation followed by 10 minutes

of questions and answers. This introductory session will

provide participants with a big picture of SP and

research, i.e. SP concepts, Top 10 current issues in SP

and some barriers to SP research. Then all participants

will be asked to complete a self-administered question-

naire for 15 minutes. After that, they will be split into

several focus groups to discuss their barriers to SP

research for 45 minutes. The last 15 minutes will be spent

on the wrap-up summary.

Additional information: A self-completed questionnaire

needs to be provided for all workshop participants. For

the focus group session, a flipchart per group is

required.

How to Improve Dose Administration Aids for AgedCare FacilitiesJ.F.M. Gilmartin1, S.Y. Hussainy1, J.L. Marriott1,1Centre for Medicine Use and Safety, Monash University,

Parkville, Melbourne, Victoria, Australia

Introduction: Our previous research found that 11.6% of

3,959 audited dose administration aids (DAAs) from

49 Australian residential aged care facilities (RACFs)

suffered from incidents. The DAAs included blister packs

and sachets supplied by pharmacies and used formedicine

administration. The top five incident types included:

unsuitable for packing according to pharmaceutical

packing guidelines; addition of a medicine; incorrect

quantity packed and missing or damaged medicines.

This workshop is designed to educate participants on

these incidents and their potential contributing factors.

Additionally, participants will be asked to evaluate and

modify simulated quality improvement initiatives de-

signed to increase the accuracy of and appropriateness

of DAA packing.

Aims of the Workshop: This workshop is aimed to gain

a greater understanding of the problems associated with

DAA preparation and supply to RACFs, to increase

awareness of factors that may hinder or facilitate

accurate and appropriate DAApreparation, and to equip

participants with the knowledge and skills to develop

quality improvement initiatives in their local setting that

are targeted at DAA preparation and supply.

Learning Objectives: At the end of this workshop,

participants should be able to:

1. Outline the common types of incidents that may oc-

cur in DAAs and explain why they may occur

2. Outline possible quality improvement strategies to

prevent DAA incidents from occurring and explain

their benefits to pharmacy and RACFs

3. Evaluate simulated quality improvement initiatives

and suggest methods to overcome barriers to

implementation

Description of Workshop Activities: Participants will:

1. Be informed of DAA incidents that may occur (as

identified through auditing activities) and contribut-

ing factors to incidents (as identified through stake-

holder focus groups) (30 minute PowerPoint)

2. Be presented with simulated quality improvement

initiatives designed to encourage communication

and improve relationships between members of the

aged care health team, as well as assist in incident

notification and checking processes. (15 minute

PowerPoint)